Monday, February 22, 2010
Lawyers, Drugs & Money: A Prescription for Antitrust Enforcement in the Pharmaceutical Industry Online Proceedings
In cooperation with The University of San Francisco School of Law and the Rutgers Law Journal, the Legal Scholarship Network (LSN) is pleased to announce the Lawyers, Drugs & Money: A Prescription for Antitrust Enforcement in the Pharmaceutical Industry Online Proceedings. These proceedings are available to all users at no charge and contain abstracts of the meeting's papers with links to the full text within the SSRN eLibrary.
One of the most pressing issues of our time is how to encourage medical innovation while containing the costs of medication. Judges grapple with this challenge in litigation over patent rights and antitrust law. The result is a potent dose of lawyers, drugs and money, the topic of our symposium.
The University of San Francisco School of Law hosted a day-long symposium on Friday, September 25, 2009 in Fromm Hall. The symposium included five panels addressing cutting edge issues relevant to enforcement of the antitrust laws in the pharmaceutical industry. These panels considered topics such as reverse payments (or pay-for-delay settlements), product hopping, standing and preemption, burdens of proof, and class certification in antitrust cases.
You can browse all Lawyers, Drugs & Money: A Prescription for Antitrust Enforcement in the Pharmaceutical Industry Symposium abstracts in the SSRN database by clicking on the following link. The current drafts of the papers are available now and the final versions should be uploaded soon. You may wish to bookmark it in your browser.
View papers: http://www.ssrn.com/link/Lawyers-Drugs-Money.html.